(INNS)
BOSEROLIMAB(INND)
BOSEROLIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS CD27 (TNFRSF7, TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 7)], MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-446) [VH (HOMO SAPIENS IGHV1-2*02 (79.6%) -(IGHD) -IGHJ6*01 (100%), CDR-IMGT [8.8.9] (26- 33.51-58.97-105)) (1-116) -HOMO SAPIENS IGHG1*01, G1M17,1 (CH1 K120 (213) (117-214), HINGE 1-15 (215-229), CH2 (230- 339), CH3 D12 (355), L14 (357) (340-444), CHS (445-446)) (117-446)], (219-213')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-213') [V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV4-59*01 (80.9%) -IGKJ4*01 (91.7%) S120>Q (104)/HOMO SAPIENS IGKV3-11*01 (80.0%) -IGKJ2*02 (100%), CDR-IMGT [5.3.9] (27- 31.49-51.88-96)) (1'-106') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (152), V101 (190) (107'-213')]; DIMER (225-225'':228-228'')- BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, DERIVED FROM THE CELL LINE CHO-K1, GLYCOFORM ALFA(WHO)
BOSEROLIMABUM(INN)